ClinicalThought
View More
Gain insights from international experts on current best practice and emerging strategies for immune checkpoint inhibition in patients with endometrial cancer.
This educational program is intended for clinicians practicing medicine outside of the United States.
Is immunotherapy suitable/appropriate for the treatment of endometrial cancer? Read my thoughts on why genetic profiling of endometrial cancer is important and which patients may benefit from single-agent immunotherapy or immunotherapy-based combinations.
This educational activity is intended for clinicians practicing medicine outside of the United States.
Domenica Lorusso, MD, PhD
Released: February 25, 2021
Read my thoughts to learn how the management of endometrial cancer continues to evolve with the use of immunotherapies as single agents or in combinations.
Maria-Pilar Barretina-Ginesta, MD
Released: June 28, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.